Yang, R.; Liu, Y.; Yang, N.; Zhang, T.; Hou, J.; He, Z.; Wang, Y.; Sun, X.; Shen, J.; Jiang, H.;
et al. Combination of miR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer. Pharmaceutics 2024, 16, 570.
https://doi.org/10.3390/pharmaceutics16040570
AMA Style
Yang R, Liu Y, Yang N, Zhang T, Hou J, He Z, Wang Y, Sun X, Shen J, Jiang H,
et al. Combination of miR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer. Pharmaceutics. 2024; 16(4):570.
https://doi.org/10.3390/pharmaceutics16040570
Chicago/Turabian Style
Yang, Rulei, Yiran Liu, Ning Yang, Tian Zhang, Jiazhen Hou, Zongyan He, Yutong Wang, Xujie Sun, Jingshan Shen, Hualiang Jiang,
and et al. 2024. "Combination of miR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer" Pharmaceutics 16, no. 4: 570.
https://doi.org/10.3390/pharmaceutics16040570
APA Style
Yang, R., Liu, Y., Yang, N., Zhang, T., Hou, J., He, Z., Wang, Y., Sun, X., Shen, J., Jiang, H., Xie, Y., & Lang, T.
(2024). Combination of miR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer. Pharmaceutics, 16(4), 570.
https://doi.org/10.3390/pharmaceutics16040570
